Postadzhiyan Arman, Yotov Yoto, Tisheva-Gospodinova Snejanka, Nikolov Fedya, Ramchev Konstantin, Raev Dimitar, Kiru Gaia, Beaney Thomas, Janssen-Telders Carolina, Poulter Neil R
Department of Cardiology, Medical University, Saint Anna University Hospital, 1, D. Mollov str, Sofia 1784, Bulgaria.
Department of Cardiology, Medical University, Varna, Bulgaria.
Eur Heart J Suppl. 2024 Jul 24;26(Suppl 3):iii20-iii22. doi: 10.1093/eurheartjsupp/suae040. eCollection 2024 Jun.
Cardiovascular disease is not only the leading cause of mortality in Bulgaria, but the associated mortality rate is twice the European Union average, so screening programmes that identify subjects with elevated blood pressure (BP) are of utmost importance. May Measurement Month (MMM) is an annual global initiative that began in 2017 that aims to raise awareness of high BP. Bulgaria first joined the third campaign of MMM in 2019, and an overview of the results of Bulgarian participation in MMM21 is presented in this paper. Hypertension was defined as receiving BP-lowering medications or having a systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg. Statistical analysis followed the standard MMM protocol. In Bulgaria, 155 screening sites were set up in primary and secondary care facilities, in pharmacies, and outdoor spaces across 16 administrative districts. Out of 3908 individuals screened, 2896 participants (74.1%) had hypertension. Of 2896 participants with hypertension, 76.4% were on treatment of whom 48.5% had controlled BP (<140/90 mmHg). Out of 1696 participants not on antihypertensive medication, 684 (40.3%) had elevated BP. Men were found to have higher rates of undiagnosed hypertension and lower rates of control than women. By identifying almost two-thirds of the whole screened cohort with the possibility of newly diagnosed or uncontrolled hypertension, our results confirm the importance of BP screening.
心血管疾病不仅是保加利亚的主要死因，而且其相关死亡率是欧盟平均水平的两倍，因此识别血压（BP）升高患者的筛查项目至关重要。五月测量月（MMM）是一项始于2017年的年度全球倡议，旨在提高对高血压的认识。保加利亚于2019年首次参加了MMM的第三次活动，本文介绍了保加利亚参与MMM21的结果概述。高血压的定义为正在接受降压药物治疗或收缩压≥140 mmHg或舒张压≥90 mmHg。统计分析遵循标准的MMM方案。在保加利亚，在16个行政区的初级和二级医疗设施、药店及户外场所设立了155个筛查点。在3908名接受筛查的个体中，2896名参与者（74.1%）患有高血压。在2896名高血压参与者中，76.4%正在接受治疗，其中48.5%的人的血压得到控制（<140/90 mmHg）。在1696名未服用抗高血压药物的参与者中，684人（40.3%）血压升高。研究发现，男性未诊断高血压的比例高于女性，血压控制率低于女性。通过识别几乎三分之二的筛查队列中可能新诊断或血压未得到控制的高血压患者，我们的结果证实了血压筛查的重要性。
